In short
Evidence
Independent clinical study
In a university cohort of 207 NobelActive® implants, overall survival was 91.5%; survival was lower in patients with both local and systemic risk factors (76.5%) than in patients without risk factors (94.8%). 1
Small retrospective study; shows that patient factors matter more than the implant name.
Consensus / guideline
The EFP S3 clinical guideline on peri-implant diseases centres prevention on oral hygiene, regular supportive care and managing risk factors such as smoking. 3
Next
Would you like a dentist to assess whether this treatment suits you?
Request an assessment
Clinical review pending. Facts on this page are checked against the sources listed below (regulatory records, manufacturer documents, peer-reviewed research). A named clinician will review it before we call it medically reviewed.
Last updated 28 Sep 2026 · How we review
Last updated 28 Sep 2026 · How we review
Sources
- Independent clinical studySaridakis SK et al. Tapered implant with high primary stability in patients with local and systemic risk factors: 7-year data. Int J Implant Dent 2018 — Int J Implant Dent, 2018. Accessed 28 Sep 2026.
- Independent clinical studyMaló P et al. The All-on-4 concept for the edentulous maxilla: longitudinal study with 5–13 years of follow-up. Clin Implant Dent Relat Res 2019 — Clin Implant Dent Relat Res, 2019. Accessed 28 Sep 2026.
- Consensus / guidelineHerrera D et al. Prevention and treatment of peri-implant diseases — EFP S3 level clinical practice guideline — J Clin Periodontol, 2023. Accessed 28 Sep 2026.
Educational information only. The choice of implant system depends on your anatomy, restorative plan, bone quality and the clinician's assessment. This website does not recommend a specific implant for you.
